Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous propofol: unique effectiveness in treating intractable migraine.

J C Krusz1, V Scott, J Belanger

  • 1Anodyne Paincare, Dallas, TX 75231-4308, USA.

Headache
|April 12, 2000
PubMed
Summary

Intravenous propofol offers a novel, highly effective treatment for intractable headaches, including migraines. This rapid-acting anesthetic agent provided significant pain relief for most patients in an outpatient headache center setting.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EMOTIONAL EXPERIENCES AND SOCIAL CHALLENGES OF OROFACIAL CLEFT IN RURAL SUB-SAHARAN AFRICA: A QUALITATIVE INTERPRETIVIST APPROACH.

Annals of Ibadan postgraduate medicine·2025
Same author

Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa.

Public health action·2022
Same author

Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

A home-based care programme for rifampicin-resistant TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021

Area of Science:

  • Neurology
  • Anesthesiology
  • Pharmacology

Background:

  • Propofol, an intravenous anesthetic, was observed to provide 100% migraine relief in six patients undergoing nerve block procedures.
  • This led to a study investigating subanesthetic doses of propofol for intractable headaches refractory to standard treatments.

Purpose of the Study:

  • To evaluate the effectiveness of intravenous propofol in treating refractory migraines and other severe headaches.
  • To establish propofol as a potential new abortive treatment option in headache clinics and emergency settings.

Main Methods:

  • Seventy-seven patients with intractable migraines and non-migrainous headaches received intravenous propofol treatment.
  • The treatment was administered in an outpatient headache clinic setting.

Related Experiment Videos

Main Results:

  • An average headache intensity reduction of 95.4% was achieved within 20-30 minutes of propofol administration.
  • Complete headache abolition was reported by 63 out of 77 patients, with minimal recurrence.
  • The average propofol dose was subanesthetic (110 mg), well within preanesthetic ranges.

Conclusions:

  • Intravenous propofol demonstrates rapid and highly effective abortive treatment for severe, intractable headaches.
  • Propofol offers a promising alternative to existing treatments for acute migraine and other refractory headache conditions.
  • The efficacy of propofol prompts further investigation into the neuropharmacology and pathophysiology of migraines.